GLP-1 receptor agonists are subcutaneous injections delivered into fatty tissue beneath the skin, not into muscle or veins
We have also performed a complete dose study by delivering glucose loads from zero to 125 mg to female wildtype and GIP receptor KO and GLP-1 receptor KO mice
Last reviewed: July 1, 2026 Last updated: July 1, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Obviously, it is too early to be overly hopeful since it is still necessary to determine the long-term effects of these compounds and properly verify the potential cardiovascular benefits
Sin embargo, la recomendacin tambin enfatiza un monitoreo cercano, reducciones graduales en las dosis de insulina, mantener una ingesta adecuada de carbohidratos, pruebas de cetonas, reglas para das de enfermedad y una cuidadosa titulacin de dosis [4]